These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cooperative interactions of p53 mutation, telomere dysfunction, and chronic liver damage in hepatocellular carcinoma progression. Farazi PA; Glickman J; Horner J; Depinho RA Cancer Res; 2006 May; 66(9):4766-73. PubMed ID: 16651430 [TBL] [Abstract][Full Text] [Related]
4. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Rudolph KL; Millard M; Bosenberg MW; DePinho RA Nat Genet; 2001 Jun; 28(2):155-9. PubMed ID: 11381263 [TBL] [Abstract][Full Text] [Related]
5. Hepatocellular telomere shortening correlates with chromosomal instability and the development of human hepatoma. Plentz RR; Caselitz M; Bleck JS; Gebel M; Flemming P; Kubicka S; Manns MP; Rudolph KL Hepatology; 2004 Jul; 40(1):80-6. PubMed ID: 15239089 [TBL] [Abstract][Full Text] [Related]
6. Telomeres and telomerase: a dual role in hepatocarcinogenesis. Satyanarayana A; Manns MP; Rudolph KL Hepatology; 2004 Aug; 40(2):276-83. PubMed ID: 15368430 [TBL] [Abstract][Full Text] [Related]
7. Sirtuin 1 is upregulated in a subset of hepatocellular carcinomas where it is essential for telomere maintenance and tumor cell growth. Chen J; Zhang B; Wong N; Lo AW; To KF; Chan AW; Ng MH; Ho CY; Cheng SH; Lai PB; Yu J; Ng HK; Ling MT; Huang AL; Cai XF; Ko BC Cancer Res; 2011 Jun; 71(12):4138-49. PubMed ID: 21527554 [TBL] [Abstract][Full Text] [Related]
8. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status. Saini N; Srinivasan R; Chawla Y; Sharma S; Chakraborti A; Rajwanshi A Liver Int; 2009 Sep; 29(8):1162-70. PubMed ID: 19627485 [TBL] [Abstract][Full Text] [Related]
9. Telomerase deficiency and telomere dysfunction inhibit mammary tumors induced by polyomavirus middle T oncogene. Jaskelioff M; Song W; Xia J; Liu C; Kramer J; Koido S; Gendler SJ; Calderwood SK; Gong J Oncogene; 2009 Dec; 28(48):4225-36. PubMed ID: 19734944 [TBL] [Abstract][Full Text] [Related]
10. Telomerase antagonists GRN163 and GRN163L inhibit tumor growth and increase chemosensitivity of human hepatoma. Djojosubroto MW; Chin AC; Go N; Schaetzlein S; Manns MP; Gryaznov S; Harley CB; Rudolph KL Hepatology; 2005 Nov; 42(5):1127-36. PubMed ID: 16114043 [TBL] [Abstract][Full Text] [Related]
11. Telomere length variation and maintenance in hepatocarcinogenesis. Yokota T; Suda T; Igarashi M; Kuroiwa T; Waguri N; Kawai H; Mita Y; Aoyagi Y Cancer; 2003 Jul; 98(1):110-8. PubMed ID: 12833463 [TBL] [Abstract][Full Text] [Related]
12. Telomere shortening correlates with increasing aneuploidy of chromosome 8 in human hepatocellular carcinoma. Plentz RR; Schlegelberger B; Flemming P; Gebel M; Kreipe H; Manns MP; Rudolph KL; Wilkens L Hepatology; 2005 Sep; 42(3):522-6. PubMed ID: 16116624 [TBL] [Abstract][Full Text] [Related]
13. Positive association of long telomeres with the invasive capacity of hepatocellular carcinoma cells. Ko E; Jung G Biochem Biophys Res Commun; 2014 May; 447(2):358-63. PubMed ID: 24732358 [TBL] [Abstract][Full Text] [Related]
14. Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease. Calvisi DF; Pinna F; Ladu S; Pellegrino R; Muroni MR; Simile MM; Frau M; Tomasi ML; De Miglio MR; Seddaiu MA; Daino L; Sanna V; Feo F; Pascale RM Carcinogenesis; 2008 Aug; 29(8):1639-47. PubMed ID: 18579559 [TBL] [Abstract][Full Text] [Related]
15. Telomere dysfunction: multiple paths to the same end. Harrington L; Robinson MO Oncogene; 2002 Jan; 21(4):592-7. PubMed ID: 11850784 [TBL] [Abstract][Full Text] [Related]
16. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect. Marotta F; Vangieri B; Cecere A; Gattoni A Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567 [TBL] [Abstract][Full Text] [Related]
17. Balancing instability: dual roles for telomerase and telomere dysfunction in tumorigenesis. Hackett JA; Greider CW Oncogene; 2002 Jan; 21(4):619-26. PubMed ID: 11850787 [TBL] [Abstract][Full Text] [Related]
18. [Telomere length and telomerase activity in hepatocellular carcinoma]. Nakashio R; Kitamoto M; Nakanishi T; Takaishi H; Takahashi S; Kajiyama G Nihon Rinsho; 1998 May; 56(5):1239-43. PubMed ID: 9613130 [TBL] [Abstract][Full Text] [Related]
19. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County. Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489 [TBL] [Abstract][Full Text] [Related]
20. [Expression of human telomerase reverse transcriptase gene in HCC does not depend on proliferating cell nuclear antigen and P53]. Zhang D; Li KZ; Dou KF; Gao ZQ; Song ZS; Zhao QC; Fu YC Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Nov; 20(6):721-2. PubMed ID: 15555445 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]